COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Dirk Heerwegh
Institution
Janssen Research & Development
Address
Beerse
Belgium
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2015
1
2016
1
2020
1
2021
3
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Alter G
,
Yu J
,
Liu J
,
Chandrashekar A
,
Borducchi EN
,
Tostanoski LH
,
McMahan K
,
Jacob-Dolan C
,
Martinez DR
,
Chang A
,
Anioke T
,
Lifton M
,
Nkolola J
,
Stephenson KE
,
Atyeo C
,
Shin S
,
Fields P
,
Kaplan I
,
Robins H
,
Amanat F
,
Krammer F
,
Baric RS
,
Le Gars M
,
Sadoff J
,
de Groot AM
,
Heerwegh D
,
Struyf F
,
Douoguih M
,
van Hoof J
,
Schuitemaker H
,
Barouch DH
. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature. 2021 08; 596(7871):268-272.
PMID:
34107529
.
Citations:
24
Fields:
Sci
Science
Translation:
Humans
CT
Clinical Trials
Stephenson KE
,
Le Gars M
,
Sadoff J
,
de Groot AM
,
Heerwegh D
,
Truyers C
,
Atyeo C
,
Loos C
,
Chandrashekar A
,
McMahan K
,
Tostanoski LH
,
Yu J
,
Gebre MS
,
Jacob-Dolan C
,
Li Z
,
Patel S
,
Peter L
,
Liu J
,
Borducchi EN
,
Nkolola JP
,
Souza M
,
Tan CS
,
Zash R
,
Julg B
,
Nathavitharana RR
,
Shapiro RL
, Azim AA,
Alonso CD
,
Jaegle K
,
Ansel JL
,
Kanjilal DG
,
Guiney CJ
,
Bradshaw C
,
Tyler A
,
Makoni T
,
Yanosick KE
,
Seaman MS
,
Lauffenburger DA
,
Alter G
,
Struyf F
,
Douoguih M
,
Van Hoof J
,
Schuitemaker H
,
Barouch DH
. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 04 20; 325(15):1535-1544.
PMID:
33704352
.
Citations:
56
Fields:
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Sadoff J
,
Le Gars M
,
Shukarev G
,
Heerwegh D
,
Truyers C
,
de Groot AM
,
Stoop J
,
Tete S
,
Van Damme W
,
Leroux-Roels I
,
Berghmans PJ
,
Kimmel M
,
Van Damme P
,
de Hoon J
,
Smith W
,
Stephenson KE
,
De Rosa SC
,
Cohen KW
,
McElrath MJ
,
Cormier E
,
Scheper G
,
Barouch DH
,
Hendriks J
,
Struyf F
,
Douoguih M
,
Van Hoof J
,
Schuitemaker H
. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med. 2021 05 13; 384(19):1824-1835.
PMID:
33440088
.
Citations:
252
Fields:
Med
Medicine (General)
Translation:
Humans
Cells
CT
Clinical Trials
Custers J
,
Kim D
,
Leyssen M
,
Gurwith M
,
Tomaka F
,
Robertson J
,
Heijnen E
,
Condit R
,
Shukarev G
,
Heerwegh D
,
van Heesbeen R
,
Schuitemaker H
,
Douoguih M
,
Evans E
,
Smith ER
,
Chen RT
. Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 2021 05 21; 39(22):3081-3101.
PMID:
33676782
.
Citations:
13
Fields:
All
Allergy and Immunology
Translation:
Humans
Animals
Cells
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs